MasonWrightFreemanMD
Endocrinology • Boston, MADiabetes, Lipid Metabolism
Professor of Medicine Chief, Lipid Metabolism Unit
Dr. Freeman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Simches 7214
185 Cambridge St
Boston, MA 02114Phone+1 617-724-7704Fax+1 617-726-2879
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1985 - 1985- Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1984
University of California San Francisco School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1981 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers Start of enrollment: 2009 Feb 01
- Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes Start of enrollment: 2009 Jun 01
- Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 116 citationsABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux.Michael L. Fitzgerald, A.L. Morris, Angeliki Chroni, Armando J. Mendez, Vassilis I. Zannis
Journal of Lipid Research. 2004-02-01 - 315 citationsEffect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.George L. Bakris, Bertram Pitt, Matthew R. Weir, Mason W. Freeman, Martha Mayo
JAMA. 2015-07-14 - 1231 citationsPattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.Evelyn A. Kurt-Jones, Lana Popova, Laura Kwinn, Lia M. Haynes, Les P. Jones
Nature Immunology. 2000-11-01
Press Mentions
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific SessionsNovember 8th, 2022- CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming American Society of Nephrology Kidney Week 2022October 25th, 2022
- CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension ResearchOctober 21st, 2022
- Join now to see all
Grant Support
- Analysis Of ABCA Transporter Function In Homologous Recombinant MiceNational Center For Research Resources2006–2009
- Cell Biology Of ABCA1National Heart, Lung, And Blood Institute2002–2006
- Genomic Analysis Of Stress And InflammationNational Heart, Lung, And Blood Institute2003–2004
- Shared Microarray FacilityNational Heart, Lung, And Blood Institute2002–2004
- Development And Characterization Of CD14 Deficient MiceNational Center For Research Resources2001–2004
- Macrophage Scavenger Receptor In AtherosclerosisNational Heart, Lung, And Blood Institute2000–2003
- Macrophaage Lipid Receptors In AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
- Core--Molecular/Cell BiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
- Core--Molecular BiologyEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1999
- Regulation Of Scavenger Receptors In AtherosclerosisNational Heart, Lung, And Blood Institute1990–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
